ZB
HZNP

Zions Bancorporation’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Zions Bancorporation’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7
Closed -$810 – 926
2023
Q3 		$810 Hold
7
– – ﹤0.01% 854
2023
Q2 		$720 Hold
7
– – ﹤0.01% 858
2023
Q1 		$764 Hold
7
– – ﹤0.01% 864
2022
Q4 		$797 Buy
+7
New +$581 ﹤0.01% 1010
2022
Q3 		– Sell
-16
Closed -$1K – 1113
2022
Q2 		$1K Sell
16
-27
-63% -$2.56K ﹤0.01% 1063
2022
Q1 		$5K Buy
43
+27
+169% +$2.63K ﹤0.01% 976
2021
Q4 		$2K Sell
16
-2
-11% -$218 ﹤0.01% 951
2021
Q3 		$2K Buy
18
+2
+13% +$208 ﹤0.01% 958
2021
Q2 		$1K Hold
16
– – ﹤0.01% 973
2021
Q1 		$1K Hold
16
– – ﹤0.01% 945
2020
Q4 		$1K Buy
+16
New +$1.19K ﹤0.01% 930

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Zions Bancorporation's HZNP Position: Q4 2023 in Review

Zions Bancorporation sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 7 shares — an estimated $810 sold.

Zions Bancorporation first reported a position in HZNP in Q4 2020 and held it in 11 quarters. The position peaked at $5K in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Zions Bancorporation reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Zions Bancorporation sold 7 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $810.
  • Zions Bancorporation first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 11 quarters.
  • Zions Bancorporation's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Zions Bancorporation's 13F filing for Q4 2023, filed 12 Feb 2024.